CL2011000767A1 - Emulsion de aceite en agua que contiene (i) fase hidrofobica interna en cantidades desde 1 a 40 %, (ii)una fase hidrofilica externa desde 60 a 99 %, (iii) al menos un surfactante polimerico en cantidades desde 0,50 a 2,50 y (iv) al menos unprincipio activo insoluble en agua en cantidades desde 0,01 al 25 % por peso. - Google Patents

Emulsion de aceite en agua que contiene (i) fase hidrofobica interna en cantidades desde 1 a 40 %, (ii)una fase hidrofilica externa desde 60 a 99 %, (iii) al menos un surfactante polimerico en cantidades desde 0,50 a 2,50 y (iv) al menos unprincipio activo insoluble en agua en cantidades desde 0,01 al 25 % por peso.

Info

Publication number
CL2011000767A1
CL2011000767A1 CL2011000767A CL2011000767A CL2011000767A1 CL 2011000767 A1 CL2011000767 A1 CL 2011000767A1 CL 2011000767 A CL2011000767 A CL 2011000767A CL 2011000767 A CL2011000767 A CL 2011000767A CL 2011000767 A1 CL2011000767 A1 CL 2011000767A1
Authority
CL
Chile
Prior art keywords
amounts
water
phase
iii
oil
Prior art date
Application number
CL2011000767A
Other languages
English (en)
Spanish (es)
Inventor
Emanuela Mura
Federico Mailland
Daniela Ceriani
Original Assignee
Polichem Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40340663&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2011000767(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Polichem Sa filed Critical Polichem Sa
Publication of CL2011000767A1 publication Critical patent/CL2011000767A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/345—Nitrofurans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Endocrinology (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Colloid Chemistry (AREA)
CL2011000767A 2008-10-08 2011-04-06 Emulsion de aceite en agua que contiene (i) fase hidrofobica interna en cantidades desde 1 a 40 %, (ii)una fase hidrofilica externa desde 60 a 99 %, (iii) al menos un surfactante polimerico en cantidades desde 0,50 a 2,50 y (iv) al menos unprincipio activo insoluble en agua en cantidades desde 0,01 al 25 % por peso. CL2011000767A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP08166058A EP2174650A1 (en) 2008-10-08 2008-10-08 Modified release emulsions for application to skin or vaginal mucosa

Publications (1)

Publication Number Publication Date
CL2011000767A1 true CL2011000767A1 (es) 2011-06-17

Family

ID=40340663

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2011000767A CL2011000767A1 (es) 2008-10-08 2011-04-06 Emulsion de aceite en agua que contiene (i) fase hidrofobica interna en cantidades desde 1 a 40 %, (ii)una fase hidrofilica externa desde 60 a 99 %, (iii) al menos un surfactante polimerico en cantidades desde 0,50 a 2,50 y (iv) al menos unprincipio activo insoluble en agua en cantidades desde 0,01 al 25 % por peso.

Country Status (19)

Country Link
US (1) US20110195944A1 (enExample)
EP (2) EP2174650A1 (enExample)
JP (1) JP2012505171A (enExample)
KR (1) KR20110067115A (enExample)
CN (1) CN102170862A (enExample)
AR (1) AR073801A1 (enExample)
AU (1) AU2009301275A1 (enExample)
BR (1) BRPI0920565A2 (enExample)
CA (1) CA2737255A1 (enExample)
CL (1) CL2011000767A1 (enExample)
CO (1) CO6361898A2 (enExample)
EA (1) EA201170555A1 (enExample)
IL (1) IL211681A0 (enExample)
MA (1) MA32687B1 (enExample)
MX (1) MX2011003696A (enExample)
NZ (1) NZ591919A (enExample)
PE (1) PE20110449A1 (enExample)
WO (1) WO2010040632A1 (enExample)
ZA (1) ZA201101818B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2667852B1 (en) * 2011-01-27 2016-11-09 GlaxoSmithKline Biologicals SA Adjuvant nanoemulsions with crystallisation inhibitors
WO2012135422A2 (en) * 2011-04-01 2012-10-04 University Of Florida Research Foundation, Inc. Thermo-sensitive, mucoadhesive or dermoadhesive, and penetration-enhancing formulations for topical delivery of therapeutics
DE102011076869A1 (de) * 2011-06-01 2012-12-06 Beiersdorf Ag Emulsionszubereitungen mit verbesserten rheologischen Eigenschaften
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
HRP20211377T1 (hr) 2011-11-23 2022-01-07 Therapeuticsmd, Inc. Prirodne kombinirane hormonske supstitucijske formulacije i terapije
CN104105472A (zh) 2011-12-20 2014-10-15 维奥姆生物科学有限公司 用于治疗真菌感染的局部油组合物
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
CN105263525A (zh) * 2013-04-12 2016-01-20 维奥姆生物科学有限公司 抗微生物剂的组合物和制剂、它们的方法以及用于治疗微生物感染的方法
AU2015229421B2 (en) * 2014-03-12 2020-06-04 Allergan Therapeutics LLC Low-dose estradiol cream
KR20170005819A (ko) 2014-05-22 2017-01-16 쎄러퓨틱스엠디, 인코퍼레이티드 천연 복합 호르몬 대체 제형 및 요법
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
KR20180126582A (ko) 2016-04-01 2018-11-27 쎄러퓨틱스엠디, 인코퍼레이티드 스테로이드 호르몬 약제학적 조성물
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
US11026883B2 (en) * 2016-10-13 2021-06-08 Catalent U.K. Swindon Zydis Limited Lyophilized pharmaceutical compositions for vaginal delivery
KR20250024864A (ko) * 2017-06-22 2025-02-19 비라말 리미티드 약물 전달을 위한 조성물 및 그의 사용 방법
WO2019213473A1 (en) 2018-05-04 2019-11-07 The Procter & Gamble Company Compositions and methods for treating vaginal dryness
EP3659583B1 (en) 2018-11-30 2023-06-07 Viramal Limited A method of preparing a gelling agent, the gelling agent obtained thereby, and the use of said gelling agent

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1349545T3 (da) * 2000-12-05 2009-02-16 Los Angeles Childrens Hospital Farmaceutiske præparater af fenretinid med öget biotilgængelighed samt fremgangsmåder til anvendelse deraf
CA2480225A1 (en) * 2002-04-04 2003-10-16 Eugene H. Gans Methods for treating rosacea with pyridones
US20060018937A1 (en) * 2002-10-25 2006-01-26 Foamix Ltd. Steroid kit and foamable composition and uses thereof
US20060233721A1 (en) * 2002-10-25 2006-10-19 Foamix Ltd. Foam containing unique oil globules
US20040087564A1 (en) * 2002-10-31 2004-05-06 Wright D. Craig Delivery composition and method
WO2007099396A2 (en) * 2005-06-07 2007-09-07 Foamix Ltd. Antibiotic kit and composition and uses thereof
US20070071705A1 (en) * 2005-09-29 2007-03-29 De Oliveira Monica A M Topical anti-microbial compositions
US20080075745A1 (en) * 2006-09-21 2008-03-27 Glenmark Pharmaceuticals Limited Topical pharmaceutical compositions containing ciclopirox or a pharmaceutically acceptable salt thereof

Also Published As

Publication number Publication date
MA32687B1 (fr) 2011-10-02
NZ591919A (en) 2012-09-28
AU2009301275A2 (en) 2011-04-28
ZA201101818B (en) 2012-05-30
IL211681A0 (en) 2011-06-30
WO2010040632A1 (en) 2010-04-15
US20110195944A1 (en) 2011-08-11
JP2012505171A (ja) 2012-03-01
CN102170862A (zh) 2011-08-31
KR20110067115A (ko) 2011-06-21
AR073801A1 (es) 2010-12-01
PE20110449A1 (es) 2011-07-07
BRPI0920565A2 (pt) 2015-12-29
EA201170555A1 (ru) 2011-12-30
EP2174650A1 (en) 2010-04-14
MX2011003696A (es) 2011-06-20
CO6361898A2 (es) 2012-01-20
AU2009301275A1 (en) 2010-04-15
CA2737255A1 (en) 2010-04-15
EP2331065A1 (en) 2011-06-15

Similar Documents

Publication Publication Date Title
CL2011000767A1 (es) Emulsion de aceite en agua que contiene (i) fase hidrofobica interna en cantidades desde 1 a 40 %, (ii)una fase hidrofilica externa desde 60 a 99 %, (iii) al menos un surfactante polimerico en cantidades desde 0,50 a 2,50 y (iv) al menos unprincipio activo insoluble en agua en cantidades desde 0,01 al 25 % por peso.
MX2010002340A (es) Formulacion en emulsion estable que dificulta la interaccion a traves de la interfase agua-aceite.
ECSP088668A (es) Sistema de administracion de plaguicidas
UY29005A1 (es) Composiciones plaguicidas líquidas.-
CR20140539A (es) Preparación que contiene por lo menos un fungicida conazólico
CL2013000437A1 (es) Forma de dosificacion farmaceutica con resistencia a la rotura de al menos 500 n, que contiene un ingrediente activo, 5 al 70 % en peso de una sal inorganica, al menos 30% en peso de un oxido de polialquileno, en donde el ingrediente activo esta integrado en una matriz de liberacion controlada que comprende la sal inorganica y el oxido de polialquileno.
DOP2010000318A (es) Formulaciones mejoradas para ingredientes farmaceuticos activos de permeabilidad deficiente
AR065065A1 (es) Composicion agroquimica liquida que contiene compuesto hidrofobico agroquimicamente activo
CL2010001619A1 (es) Composiciones que comprenden una silicona de formula definida y un componente adicional; metodo para formular dichas composiciones; y emulsiones acuosas y no acuosas que comprenden a dichas composiciones (div. sol. n° 656-07).
CO6251306A2 (es) Fabricacion procesamiento empaque y administracion de una bebida utilizando agua activada electroquimicamente
PE20151519A1 (es) Composicion de liposoma
AR071561A1 (es) Formulaciones de emulsion de pickering
MX2009004767A (es) Preparacion liquida que comprende un complejo de pimobendan y ciclodextrina.
ATE493970T1 (de) Konservierungsmittelfreie augenlösung auf prostaglandin-basis
CO6280437A2 (es) Una composicion de emulsion de aceite en agua que tiene una fase de agua y nua fase de aceite comprendiendo un modificador polimerico y un compuesto activo agricolamente
CO6382078A2 (es) Agente rodenticida sinergico
GT200800247A (es) Papel impregnado con principios activos insecticidas
AR116485A2 (es) Una mayonesa libre de edta
CL2008002780A1 (es) Combinacion de principios activos que contienen al menos un compuesto derivado de 5h-furan-2-ona y al menos un principio activo de los neonicotinoides; uso de dicha combinación; procedimiento para combatir animales nocivos.
CL2013003128A1 (es) Composición herbicida que comprende a) una fase de aceite discontinua que comprende un principio activo y un solvente orgánico inmiscible en agua, b) una fase acuosa continua que comprende una sal de glifosato y agua, y c) al menos dos tensioactivos emulsionantes de copolímero en bloque; método de preparación.
AR086395A1 (es) Envase para el tratamiento de patologias
CL2015001565A1 (es) Composición, en forma de suspensión acuosa, que comprende al menos un compuesto de triazina, un principio activo adicional y uno o más tensioactivos; kit que comprende la composición; método de preparación y uso de un tesioactivo.
CO6280579A2 (es) Una composicion que mejora el efecto de control de un compuesto de antranilamida contra las plagas
CL2008000217A1 (es) Combinaciones de compuestos activos que comprenden la formononetina y al menos un compuesto activo; uso de dicha combinacion para controlar hongos fitopatogenos no deseados; y procedimiento para controlar hongos fitopatogenos no deseados.
BRPI0910110A2 (pt) Emulsões óleo-em-água estabilizadas incluindo ingredientes agricolamente ativos